Reported OECD statistic does not prove that Irish pharmaceutical expenditure per capita is highest in Europe (02/15/2016)

e-Learning version of IPHA Code of Practice for the Pharmaceutical Industry launched (02/05/2016)

Dr Leisha Daly, IPHA President remarks at the Primary Care Partnership Conference, 28th January 2016 (01/28/2016)

Good news on Health: Euro Health Index shows Ireland in Top 5 for pharmaceuticals (01/26/2016)

New research and development strategy has the potential to make Ireland a global innovation leader - IPHA (12/08/2015)

GSK’s Dave Barrett appointed to the Board of the Irish Pharmaceutical Healthcare Association (12/03/2015)

IPHA comments on OECD Health at a Glance (11/04/2015)

IPHA welcomes publication of HPRA guidance on biosimilars (10/16/2015)
The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed the publication of the HPRA’s Guide to Biosimilars for Healthcare Professionals and Patients. IPHA believes that biosimilars have a role to play in healthcare and that this guidance document provides valuable information on the regulation, prescribing, dispensing and traceability of biosimilar medicines in Ireland.

IPHA responds to Oireachtas Committee report on cost of pharmaceuticals (10/09/2015)
The Irish Pharmaceutical Healthcare Association (IPHA) has commented on a report published today by the Joint Oireachtas Committee on Health and Children on the cost of prescription pharmaceuticals in Ireland.

Pharmaceutical industry reponds to discussions on price at the European Health Forum (10/02/2015)
Following discussions today at European Health Forum Gastein, Austria, the European Federation of Pharmaceutical Industries and Associations (EFPIA) of which the Irish Pharmaceutical Healthcare Association (IPHA is a member, has moved to separate the fact from the fiction in the debate on price

 

Related Content

Petri dishes
IPHA Press Releases 

IPHA is a member of -

AESGPEFPIA

For medicines and clinical trials information visit -

medicines.ieself-care.ieICTRP Portal